For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06671912?term=lotam&limit=10&sort=@relevance&rank=1
Contact name
Laura Morse Cucci
Clinical trials study type
Clinical trials trial status
IRB number
2391476
Principal investigator
Dongyan Liu, MD
Clinical trials study number
A012301
Phone
443-849-3122
Clinical trials title (full)
A012301: LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer